Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilucoplan in Generalized Myasthenia Gravis (RAISE-XT)
NCT04225871Phase 3Completed
- Sponsor
- UCB
- Start
- Dec 2019
- Primary completion
- Jul 2026
- Modality
- Cyclic Peptides
- Countries
- 10
01
Overview
A Phase 3 trial of zilucoplan in myasthenia gravis (MG), sponsored by UCB. Started Dec 2019; status: completed.
02
Drugs
zilucoplan
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT04225871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04225871.